Ashland’s pharmaceutical excipients business team needed to change course and find a way to engage drug companies in the initial phase of projects.
RA worked with Ashland to identify what qualifies the company to directly support drug formulation projects.
A positioning statement and “proof points” were developed along with the visuals required to communicate the new value offering to the pharmaceutical industry.
Identifying what qualifies Ashland to support drug formulators, we helped the company to carry their new value proposition to market.
Icons were developed to associate ‘best practices’ drug formulating with Ashland’s pharmaceutical polymers, and expertise.